Core Viewpoint - Zhongchumai (688267) reported significant growth in revenue and net profit for 2024, indicating strong market performance and potential for future expansion [1][2]. Financial Performance - In 2024, the company achieved operating revenue of 667 million yuan, a year-on-year increase of 21.23% - The net profit attributable to shareholders reached 146 million yuan, up 89.21% year-on-year - For Q1 2025, operating revenue was 199 million yuan, a slight increase of 0.05%, with net profit at 40.71 million yuan, up 16.10% year-on-year [1]. Product Segmentation - The revenue composition for 2024 shows that special molecular sieves and catalyst series products accounted for approximately 85% of total revenue, with key products including mobile and fixed source denitration molecular sieves, caprolactam catalysts, and others - Non-molecular sieve catalyst series products contributed about 15% of revenue, including metal dehydrogenation catalysts and methanol-to-formaldehyde catalysts [1][2]. Market Position and Strategy - The company highlighted its iron-molybdenum method methanol-to-formaldehyde catalyst, which has lower production costs compared to imported products and offers high reaction efficiency and shorter supply cycles - This product has gained market recognition and broken the long-standing monopoly of foreign chemical companies, laying a solid foundation for domestic substitution [2]. - The fixed source denitration molecular sieve products are primarily used in industrial applications for NOx purification, with expected market growth due to stricter domestic emission standards [2]. Future Outlook - The company anticipates significant growth in mobile source denitration molecular sieve series products, epoxy propylene catalysts, and methanol-to-formaldehyde catalysts by 2025 [2]. - Zhongchumai aims to deepen strategic collaboration with global customers and partners, focusing on technological innovation and resource integration to enhance market share and brand value [3]. - The company is also committed to developing high-purity silicon-aluminum materials for emerging sectors like semiconductors and photovoltaics, aiming to create a technology barrier and product matrix driven by market demand [3].

Core Viewpoint - The company plans to apply for a comprehensive credit limit of up to RMB 590 million from various banks to support its operational development [1][2] Group 1: Credit Application Details - The company intends to apply for credit limits from multiple banks, including RMB 100 million from China Construction Bank, RMB 80 million from Agricultural Bank of China, and several other banks with varying limits totaling RMB 590 million [1] - The credit types include loans, acceptance bills, discounts, letters of credit, advances, guarantees, payments, and factoring, with the final terms subject to bank approval [1] - The credit application has been approved by the company's board and does not require shareholder meeting approval [1] Group 2: Management Authorization - The board has authorized the management to handle the credit and financing business within the approved limits and to sign relevant agreements on behalf of the company [2]

证券代码：688267 证券简称：中触媒 公告编号 2025-025 中触媒新材料股份有限公司 关于公司向银行申请综合授信额度的公告 该事项已经公司第四届董事会第四次会议审议通过，无需提交股东大会 审议。 公司于 2025 年 6 月 11 日召开了第四届董事会第四次会议，审议通过了《关 于公司向银行申请综合授信额度的议案》。现将相关事宜公告如下： 为满足经营发展的需要，公司拟向中国建设银行股份有限公司大连星海广场 支行申请授信额度不超过人民币 10,000 万元、中国农业银行股份有限公司大连 普兰店支行申请授信额度不超过人民币 8,000 万元、向招商银行股份有限公司大 连开发区支行申请授信额度不超过人民币 8,000 万元、向兴业银行股份有限公司 大连分行申请授信额度不超过人民币 8,000 万元、向广发银行股份有限公司大连 开发区支行申请授信额度不超过人民币 5,000 万元、向中国邮政储蓄银行股份有 限公司大连瓦房店市支行申请授信额度不超过人民币 3,000 万元、向上海浦东发 展银行股份有限公司大连分行申请授信额度不超过人民币 3,000 万元，向中信银 行股份有限公司大连分行申请授信额度不超过人民 ...

证券代码：688267 证券简称：中触媒 公告编号：2025-024 中触媒新材料股份有限公司 第四届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 中触媒新材料股份有限公司（以下简称"公司"）第四届董事会第四次会议 于 2025 年 6 月 11 日在公司会议室通过现场和通讯相结合的形式召开。本次会议 的通知于 2025 年 6 月 4 日通过电话及邮件方式通知全体董事。会议应到董事 9 名，实到董事 9 名，会议由董事长李进主持。会议的召集和召开程序符合有关法 律、行政法规、部门规章、规范性文件和公司章程的规定。会议决议合法、有效。 二、董事会会议审议情况 会议经全体参会董事表决，形成决议如下： (一)审议通过《关于公司向银行申请综合授信额度的议案》 表决结果：同意票数为 9 票；反对票数为 0 票；弃权票数为 0 票。 具体内容详见公司披露于上海证券交易所网站（www.sse.com.cn）的相关公 告及文件。 特此公告。 中触媒新材料股份有限公司董事会 1 2025 ...

申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或 "保荐机构"）作为中触媒新材料股份有限公司（以下简称"中触媒"、"上市 公司"或"公司"）首次公开发行股票并在科创板上市的保荐机构，根据《证券 发行上市保荐业务管理办法》《上海证券交易所上市公司自律监管指引第 7 号— —回购股份》等有关法律、法规的规定，对中触媒 2024 年度利润分配涉及的差 异化分红事项（以下简称"本次差异化分红"）进行了审慎核查，并出具核查意 见如下： 一、本次差异化分红的原因 申万宏源证券承销保荐有限责任公司 2023 年 8 月 29 日，公司召开第三届董事会第十七次会议，审议通过了《关 于以集中竞价交易方式回购股份方案的议案》，独立董事对本次事项发表了明确 同意的独立意见。审议同意公司使用公司自有资金以集中竞价交易方式回购公司 股份，用于股权激励或员工持股计划，或用于转换上市公司发行的可转换为股票 的公司债券。回购资金总额不低于人民币 3,000 万元（含）且不超过人民币 6,000 万元（含），回购价格不超过 30.00 元/股（含），回购期限为自公司董事会审 议通过本次回购股份方案之日起 12 个月内。本次回购 ...

证券代码：688267 证券简称：中触媒 公告编号：2025-023 中触媒新材料股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东 （公司回购专用证券账户除外）。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所 是否涉及差异化分红送转：是 每股分配比例 每股现金红利0.35元（含税） 相关日期 上市公司自律监管指引第 7 号——回购股份》等相关法律、行政法规、部门规章 及其他规范性文件以及《公司章程》的有关规定，公司回购专用证券账户中的股 份不享有股东大会表决权、利润分配、公积金转增股本、认购新股和配股等权利。 3. 差异化分红送转方案： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/1 ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting the stock price to outperform the industry index by more than 15% in the next six months [5][21]. Core Views - The increase in orders from BASF has significantly boosted the company's performance, and there is optimism regarding the continuous enrichment of the company's product matrix [1][2]. - The company is expanding its industrial chain both vertically and horizontally, enhancing existing product advantages while diversifying its product offerings [9][10]. Financial Performance - The company's revenue for 2024 is projected to be 667 million yuan, a year-on-year increase of 21.23%, with a net profit of 146 million yuan, up 89.21% year-on-year [1]. - For 2025, the company expects revenues of 783 million yuan and a net profit of 190 million yuan, representing year-on-year growth rates of 17.5% and 30.8%, respectively [11]. - The company's return on equity (ROE) is expected to improve from 2.9% in 2023 to 8.0% by 2027 [1][11]. Product and Market Development - The company has established a deep cooperation with BASF, which has led to a significant increase in sales of mobile source denitrification molecular sieves, contributing to a 50.03% year-on-year revenue growth from this segment [2][9]. - The company is actively developing new markets in Southeast Asia and India while strengthening its domestic market presence in regions like Northwest and South China [10][11]. Cost and Expense Management - In 2024, the company's sales expenses increased by 25.91%, while management expenses decreased by 18.60%, indicating a focus on cost control [3]. - The financial expenses saw a significant decline of 94.31%, reflecting improved financial management [3]. Cash Flow and Financial Health - The net cash flow from operating activities for 2024 is expected to be 188 million yuan, a year-on-year increase of 75.99% [4]. - The company's cash and cash equivalents at the end of the period are projected to be 153 million yuan, down 43.24% year-on-year, indicating a need for careful cash management [4].

Group 1 - The core viewpoint of the article highlights the recent research conducted by Renqiao Asset on a listed company, focusing on the growth potential of mobile source denitration molecular sieve products, particularly in the European and American markets under strict emission standards [1] - The company, Zhongchumei, reported a revenue of 199 million yuan in Q1 2025, representing a year-on-year growth of 0.05%, and a net profit of 40.71 million yuan, which is a 16.10% increase [1] - The research team at Zhongchumei consists of 143 members, including 5 PhDs and 13 Masters, and the company has implemented various incentive measures [1] Group 2 - Zhongchumei is actively managing its market value through share buybacks, increased holdings by controlling shareholders, and cash dividends [1] - The replacement cycle of mobile source denitration molecular sieve products depends on driving mileage and fuel quality, ensuring that exhaust emissions meet standards [1]

Group 1 - The epoxy propylene sector experienced a decline of 1.90%, ranking among the top losers in the concept sector, with notable declines from companies such as Hongqiang Co., Kent Catalysis, and Hongbaoli [1] - The top gainers in the epoxy propylene sector included Bohai Chemical, Guoen Co., and Zhongchumai, with increases of 3.05%, 0.95%, and 0.69% respectively [1] - The overall market saw a net outflow of 347 million yuan from the epoxy propylene sector, with 17 stocks experiencing net outflows, and 7 stocks seeing outflows exceeding 10 million yuan [1] Group 2 - Hongbaoli led the net outflow with 198 million yuan, followed by Hangjin Technology, Hongqiang Co., and Kent Catalysis, with net outflows of 44.63 million yuan, 39.58 million yuan, and 24.99 million yuan respectively [1] - The top net inflows in the sector were seen in Bohai Chemical, Sinochem International, and China Chemical, with net inflows of 25.68 million yuan, 9.25 million yuan, and 1.62 million yuan respectively [2] - The trading volume for Hongbaoli was 21.49%, while the trading volume for Bohai Chemical was 9.36% [2]

Group 1 - A total of 26 companies were investigated by institutions on May 26, with 20 companies specifically targeted by funds [1] - The most popular company among funds was Cankin Technology, which had 13 participating funds, followed by Greebo and Hars, each with 12 funds [1] - The companies investigated belong to various sectors, including electronics, machinery, basic chemicals, and pharmaceutical biology, with three stocks from each of these sectors being highlighted [1] Group 2 - Among the companies investigated, four had a total market capitalization exceeding 50 billion yuan, with BOE Technology Group being one of them, while ten companies had a market cap below 10 billion yuan [1] - In terms of market performance, eight stocks among the investigated companies saw an increase in the last five days, with Kailer Co., Zhongsheng Pharmaceutical, and Zhongchumei leading with increases of 21.62%, 7.52%, and 5.76% respectively [1] - Conversely, twelve stocks experienced declines, with Jiangnan Yifan, Tangyuan Electric, and Greebo showing the largest drops of 5.68%, 4.34%, and 3.89% respectively [1] Group 3 - The funds that participated in the investigations included significant net inflows, with Zhongsheng Pharmaceutical receiving a net inflow of 122 million yuan, the highest among the stocks [2] - Other companies with notable net inflows included Haida Group and Kailer Co., with net inflows of 36.68 million yuan and 11.77 million yuan respectively [2] - The table of companies investigated includes various details such as stock codes, latest closing prices, five-day price changes, and industry classifications [2][3]